NorthWest Biotherapeutics Inc (NWBO)

[Poor Man -]

There is still enormous risk. This is an OTC traded stock that is funded by ongoing and substantial dilution of its stock price.

All their eggs are in one basket with MHRA. And who knows how long the approval will take? And we assume approval, but that’s not 100% certain either.

I’m not a believer that the MTD will be denied. And nobody should be investing in this stock because of how they believe a judge will rule on this motion. The fact that so much attention is devoted to this one non-core issue is telling.

A lot of potential upside, but that goes along with the big downside risk.